These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23686053)

  • 41. The role of aripiprazole in Canada: A review of clinical and drug discontinuation data. Foreword.
    McIntyre RS
    Clin Ther; 2010; 32 Suppl 1():S1-2. PubMed ID: 20152548
    [No Abstract]   [Full Text] [Related]  

  • 42. Diagnostic and therapeutic challenges in narcolepsy-related psychosis.
    Kondziella D; Arlien-Soborg P
    J Clin Psychiatry; 2006 Nov; 67(11):1817-9. PubMed ID: 17196065
    [No Abstract]   [Full Text] [Related]  

  • 43. Combined antipsychotic treatment involving clozapine and aripiprazole.
    Englisch S; Zink M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1386-92. PubMed ID: 18407391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aripiprazole-associated dyskinesia.
    Sajbel TA; Cheney EM; DeQuardo JR
    Ann Pharmacother; 2005 Jan; 39(1):200-1. PubMed ID: 15598969
    [No Abstract]   [Full Text] [Related]  

  • 45. Successful treatment of catatonia with aripiprazole in an adolescent with psychosis.
    Strawn JR; Delgado SV
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):733-5. PubMed ID: 17979595
    [No Abstract]   [Full Text] [Related]  

  • 46. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
    Adan-Manes J; Garcia-Parajua P
    J Clin Pharm Ther; 2009 Apr; 34(2):245-6. PubMed ID: 19250146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.
    Grant MJ; Baldessarini RJ
    Ann Pharmacother; 2005 Nov; 39(11):1953. PubMed ID: 16219895
    [No Abstract]   [Full Text] [Related]  

  • 48. Aripiprazole in the treatment of Alzheimer's disease.
    De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
    Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, double-blind, placebo-controlled study of aripiprazole for the treatment of psychosis in nursing home patients with Alzheimer disease.
    Streim JE; Porsteinsson AP; Breder CD; Swanink R; Marcus R; McQuade R; Carson WH
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):537-50. PubMed ID: 18591574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aripiprazole and neuroleptic malignant syndrome.
    Brunelle J; Guigueno S; Gouin P; Tamion F; Thibaut F
    J Clin Psychopharmacol; 2007 Apr; 27(2):212-4. PubMed ID: 17414250
    [No Abstract]   [Full Text] [Related]  

  • 51. Hereditary spastic paraplegia and psychosis: connected by the corpus callosum?
    Osmolak AM; Wallenberg RB; Caplan JP
    Psychosomatics; 2012; 53(1):81-4. PubMed ID: 22118709
    [No Abstract]   [Full Text] [Related]  

  • 52. [Aripiprazole: a new atypical antipsychotic drug].
    Fischer B; Davids E; Gastpar M
    Fortschr Neurol Psychiatr; 2004 Sep; 72(9):497-502. PubMed ID: 15365912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug].
    Slooff CJ; Arends J
    Ned Tijdschr Geneeskd; 2006 Feb; 150(7):400-1; author reply 401. PubMed ID: 16523806
    [No Abstract]   [Full Text] [Related]  

  • 54. Benefits of combining aripiprazole to clozapine: three case reports.
    Rocha FL; Hara C
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1167-9. PubMed ID: 16647796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reversible Pisa syndrome associated with switching from haloperidol to aripiprazole during lithium treatment.
    Huang YC; Lee Y; Lin PY
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1284-5. PubMed ID: 19635518
    [No Abstract]   [Full Text] [Related]  

  • 56. Psychosis or atypical neuroleptic malignant syndrome in an adolescent?
    Groff K; Coffey BJ
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):529-32. PubMed ID: 18928418
    [No Abstract]   [Full Text] [Related]  

  • 57. Aripiprazole treatment for depression in schizoaffective disorder.
    Nakaya M; Ohmori K
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):2012-3. PubMed ID: 18848859
    [No Abstract]   [Full Text] [Related]  

  • 58. Is aripiprazole the only choice of treatment of the patients who developed anti-psychotic agents-induced leucopenia and neutropenia? A case report.
    Yalcin DO; Goka E; Aydemir MC; Kisa C
    J Psychopharmacol; 2008 May; 22(3):333-5. PubMed ID: 18208928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
    Friedman JH; Berman RM; Goetz CG; Factor SA; Ondo WG; Wojcieszek J; Carson WH; Marcus RN
    Mov Disord; 2006 Dec; 21(12):2078-81. PubMed ID: 17013906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute dystonic reaction after initiating aripiprazole monotherapy in a 20-year-old man.
    Varkula M; Dale R
    J Clin Psychopharmacol; 2008 Apr; 28(2):245-7. PubMed ID: 18344742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.